Traders sold shares of Thermo Fisher Scientific Inc. (NYSE:TMO) on strength during trading on Friday. $25.88 million flowed into the stock on the tick-up and $47.34 million flowed out of the stock on the tick-down, for a money net flow of $21.46 million out of the stock. Of all stocks tracked, Thermo Fisher Scientific had the 0th highest net out-flow for the day. Thermo Fisher Scientific traded up $1.09 for the day and closed at $157.51

A number of equities analysts have recently weighed in on the company. Zacks Investment Research raised Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $175.00 target price on the stock in a research report on Wednesday, July 20th. BTIG Research raised Thermo Fisher Scientific from a “neutral” rating to a “buy” rating and set a $180.00 target price on the stock in a research report on Friday, July 22nd. Mizuho set a $175.00 target price on Thermo Fisher Scientific and gave the stock a “buy” rating in a research report on Thursday, July 28th. Jefferies Group lowered Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research report on Friday, April 29th. Finally, Morgan Stanley reaffirmed a “buy” rating on shares of Thermo Fisher Scientific in a research report on Thursday, May 19th. Two equities research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. The company has an average rating of “Buy” and an average target price of $159.66.

The firm has a 50-day moving average of $152.98 and a 200-day moving average of $143.93. The stock has a market capitalization of $62.04 billion and a P/E ratio of 31.51.

Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings results on Thursday, July 28th. The company reported $2.03 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.01 by $0.02. During the same quarter in the prior year, the firm earned $1.84 earnings per share. The firm had revenue of $4.54 billion for the quarter, compared to the consensus estimate of $4.50 billion. The company’s revenue for the quarter was up 6.2% compared to the same quarter last year. Analysts forecast that Thermo Fisher Scientific Inc. will post $8.15 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Monday, October 17th. Investors of record on Thursday, September 15th will be given a dividend of $0.15 per share. The ex-dividend date of this dividend is Tuesday, September 13th. This represents a $0.60 annualized dividend and a dividend yield of 0.38%.

In other Thermo Fisher Scientific news, Director Jim P. Manzi sold 1,137 shares of Thermo Fisher Scientific stock in a transaction on Friday, June 3rd. The stock was sold at an average price of $153.00, for a total transaction of $173,961.00. Following the completion of the transaction, the director now owns 38,733 shares in the company, valued at $5,926,149. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Thomas W. Loewald sold 15,000 shares of Thermo Fisher Scientific stock in a transaction on Thursday, June 2nd. The shares were sold at an average price of $152.84, for a total value of $2,292,600.00. Following the transaction, the senior vice president now owns 49,169 shares of the company’s stock, valued at approximately $7,514,989.96. The disclosure for this sale can be found here.

A number of hedge funds and institutional investors recently made changes to their positions in TMO. Edge Asset Management Inc. boosted its position in shares of Thermo Fisher Scientific by 1.7% in the fourth quarter. Edge Asset Management Inc. now owns 251,801 shares of the company’s stock worth $35,718,000 after buying an additional 4,227 shares during the last quarter. Ameritas Investment Partners Inc. boosted its position in shares of Thermo Fisher Scientific by 2.7% in the fourth quarter. Ameritas Investment Partners Inc. now owns 7,665 shares of the company’s stock worth $1,086,000 after buying an additional 204 shares during the last quarter. Tredje AP fonden boosted its position in shares of Thermo Fisher Scientific by 1.7% in the fourth quarter. Tredje AP fonden now owns 25,434 shares of the company’s stock worth $3,612,000 after buying an additional 416 shares during the last quarter. Sawtooth Asset Management Inc. boosted its position in shares of Thermo Fisher Scientific by 9,139.1% in the fourth quarter. Sawtooth Asset Management Inc. now owns 11,826 shares of the company’s stock worth $1,678,000 after buying an additional 11,698 shares during the last quarter. Finally, Davidson & Garrard Inc. boosted its position in shares of Thermo Fisher Scientific by 4.4% in the fourth quarter. Davidson & Garrard Inc. now owns 63,322 shares of the company’s stock worth $8,982,000 after buying an additional 2,648 shares during the last quarter.

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.